BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22506135)

  • 1. The Microbiological Context of HIV Resistance: Vaginal Microbiota and Mucosal Inflammation at the Viral Point of Entry.
    Schellenberg JJ; Plummer FA
    Int J Inflam; 2012; 2012():131243. PubMed ID: 22506135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular definition of vaginal microbiota in East African commercial sex workers.
    Schellenberg JJ; Links MG; Hill JE; Dumonceaux TJ; Kimani J; Jaoko W; Wachihi C; Mungai JN; Peters GA; Tyler S; Graham M; Severini A; Fowke KR; Ball TB; Plummer FA
    Appl Environ Microbiol; 2011 Jun; 77(12):4066-74. PubMed ID: 21531840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.
    Munusamy Ponnan S; Thiruvengadam K; Tellapragada C; Ambikan AT; Narayanan A; Kathirvel S; Mathayan M; Shankar J; Rajaraman A; Afshan Amanulla M; Dinesha TR; Poongulali S; Saravanan S; Murugavel KG; Swaminathan S; Velu V; Shacklett B; Neogi U; Hanna LE
    Microbiol Spectr; 2021 Oct; 9(2):e0047021. PubMed ID: 34704803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand.
    Cohen CR; Duerr A; Pruithithada N; Rugpao S; Hillier S; Garcia P; Nelson K
    AIDS; 1995 Sep; 9(9):1093-7. PubMed ID: 8527084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
    Taku O; Onywera H; Mbulawa ZZA; Businge CB; Meiring TL; Williamson AL
    Microbiol Spectr; 2022 Jun; 10(3):e0222921. PubMed ID: 35647888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
    Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexually transmitted infections and vaginal douching in a population of female sex workers in Nairobi, Kenya.
    Fonck K; Kaul R; Keli F; Bwayo JJ; Ngugi EN; Moses S; Temmerman M
    Sex Transm Infect; 2001 Aug; 77(4):271-5. PubMed ID: 11463927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial vaginosis, HIV serostatus and T-cell subset distribution in a cohort of East African commercial sex workers: retrospective analysis.
    Schellenberg JJ; Card CM; Ball TB; Mungai JN; Irungu E; Kimani J; Jaoko W; Wachihi C; Fowke KR; Plummer FA
    AIDS; 2012 Jan; 26(3):387-93. PubMed ID: 22095193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
    Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
    Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariƫn KK; Jespers V
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women.
    Wessels JM; Felker AM; Dupont HA; Kaushic C
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission.
    Armstrong E; Kaul R; Cohen CR
    J Intern Med; 2023 Apr; 293(4):433-444. PubMed ID: 36544257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers.
    Yao XD; Omange RW; Henrick BM; Lester RT; Kimani J; Ball TB; Plummer FA; Rosenthal KL
    Mucosal Immunol; 2014 Mar; 7(2):268-79. PubMed ID: 23801306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.
    Cohen CR; Lingappa JR; Baeten JM; Ngayo MO; Spiegel CA; Hong T; Donnell D; Celum C; Kapiga S; Delany S; Bukusi EA
    PLoS Med; 2012; 9(6):e1001251. PubMed ID: 22745608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Increases in Inflammation and Proapoptotic Potential Are Associated with the HESN Phenotype Observed in a Subgroup of Kenyan Female Sex Workers.
    Gluchowski M; Yu X; Abrenica B; Yao S; Kimani J; Douville RN; Ball TB; Su RC
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host Genetic Factors Associated with Vaginal Microbiome Composition in Kenyan Women.
    Mehta SD; Nannini DR; Otieno F; Green SJ; Agingu W; Landay A; Zheng Y; Hou L
    mSystems; 2020 Jul; 5(4):. PubMed ID: 32723796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
    Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
    Front Immunol; 2021; 12():730986. PubMed ID: 34594336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract.
    Lajoie J; Birse K; Mwangi L; Chen Y; Cheruiyot J; Akolo M; Mungai J; Boily-Larouche G; Romas L; Mutch S; Kimani M; Oyugi J; Ho EA; Burgener A; Kimani J; Fowke KR
    J Int AIDS Soc; 2018 Jul; 21(7):e25150. PubMed ID: 30047573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
    Masson L; Barnabas S; Deese J; Lennard K; Dabee S; Gamieldien H; Jaumdally SZ; Williamson AL; Little F; Van Damme L; Ahmed K; Crucitti T; Abdellati S; Bekker LG; Gray G; Dietrich J; Jaspan H; Passmore JS
    Sex Transm Infect; 2019 Feb; 95(1):5-12. PubMed ID: 30018088
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Shvartsman E; Perciani CT; Richmond MEI; Russell JNH; Tough RH; Vancuren SJ; Hill JE; Kavi-Icr ; Jaoko W; McKinnon LR; Sandstrom PA; MacDonald KS
    Front Immunol; 2022; 13():974195. PubMed ID: 36726972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.